All articles tagged with #parkinsons disease
Michael J. Fox reassured fans after CNN published a death notice about him, which was later removed with an apology. The 64-year-old actor, who has Parkinson's disease and spoke about his health in a 2023 documentary, addressed the incident with humor in a Threads post and highlighted his wife Tracy Pollan's support as he remains open about his condition.
CNN published an obituary-style piece for Michael J. Fox by mistake and later apologized and removed it. Fox responded with humor on Threads, noting the mix-up, while he was in Los Angeles for Paley Fest promoting Shrinking, his first on-screen appearance since 2020. He continues to work and advocate for Parkinson's research through the Michael J. Fox Foundation.
CNN briefly published a memorial package for Michael J. Fox in error and quickly removed it, prompting an apology from the network. Fox countered with a witty post on Threads saying he’s “OK,” then reflected on the mishap with humor; he continues to advocate for Parkinson’s research and recently appeared at PaleyFest. The incident echoes historical obituary glitches, like the 1998 Bob Hope misprint.
A multinational study introduces Xi–αNET, a generative model that links EEG signals (the background ξ and alpha rhythms) to the brain’s physical wiring and axonal conduction delays across ages 5–100 using the HarMNqEEG dataset. The findings show alpha frequency scales with myelin-driven conduction speed, producing a U-shaped trajectory of conduction delays with age and slower rhythms in older adults; the model also detects Parkinson’s-related alpha slowing, highlighting potential EEG-based brain-health benchmarks and early disease flagging via normative charts.
A study links gut microbiome changes in Parkinson's disease to lower levels of riboflavin (B2) and biotin (B7), reduced short-chain fatty acids, and thinning of the intestinal mucus, suggesting that oral riboflavin and biotin supplementation could be a simple therapeutic approach; findings come from analyses of patients and controls across several countries, indicating a gut–brain pathway but the treatment would likely require personalized assessment.
An international study identifies cerebrospinal fluid DOPA decarboxylase as a highly specific biomarker for Parkinson’s disease and Lewy body dementia, with CSF levels up to 2.5× higher than controls and the ability to distinguish these conditions from Alzheimer’s. Two sensitive immunoassays support strong diagnostic accuracy, and higher biomarker levels correlate with brain pathology, though standardization is needed before routine clinical use.
In Buenos Aires, Ramos Mejía Hospital runs a weekly tango-therapy program for Parkinson’s patients, pairing participants with non‑patients and guiding them through warm-ups, balance work, and classic tango steps to improve gait, stiffness, and coordination while boosting social and emotional well‑being; started about 15 years ago by neurologists and researchers, it has served roughly 100 patients and highlights tango’s potential to retrain motor control in daily activities.
Aging and Parkinson’s disease force the brain to work harder to maintain balance, producing larger brain and muscle responses even to small slips and often causing opposing muscles to stiffen. This neural inefficiency is linked to poorer balance and higher fall risk, with researchers proposing a rug-pull perturbation test as a noninvasive way to gauge brain engagement and identify at-risk individuals for targeted balance training.
A UCLA-led study published in Springer Nature Link found long-term exposure to chlorpyrifos associated with a more-than-2.5-fold increase in Parkinson's risk in humans, with mice and zebrafish experiments showing brain effects; the study is observational and cannot prove causation, and researchers note limitations such as unmeasured diet and lifestyle factors while regulators reassess chlorpyrifos use.
Valerie Perrine, the Oscar-nominated actress known for Lenny and as Miss Eve Teschmacher in the Superman films, died at 82 at her Beverly Hills home after a 15-year battle with Parkinson’s disease, announced by friend Stacey Souther; her career also included Slaughterhouse-Five and other notable screen and TV work.
Valerie Perrine, the Oscar-nominated actress famed for Lenny and as Eve Teschmacher in the Superman films, died at 82 at her Beverly Hills home after a long struggle with Parkinson’s disease diagnosed in 2015. Her career spanned Las Vegas showgirl roots to film and TV roles, including The Last American Hero, The Electric Horseman, and Can’t Stop the Music, and she remained a beloved figure in Hollywood until her death.
Robert S. Mueller III, who led the FBI after 9/11 and later as special counsel investigated ties between Trump's 2016 campaign and Russia, died in Charlottesville, Virginia at 81. Diagnosed with Parkinson's disease in 2021, he retired from public life, ending a career defined by two national traumas.
Researchers at the University of Edinburgh engineered E. coli to break down post-consumer PET plastic into L-DOPA, the frontline drug for Parkinson’s disease, marking the first demonstration of a biology-based route from plastic waste to a pharmaceutical and signaling a potentially greener, scalable way to produce medicines. The work, part of the Carbon-Loop Sustainable Biomanufacturing Hub with £14 million in EPSRC funding, aims to optimize industrial-scale production and reduce reliance on fossil-fuel–based pharmaceutical processes.
A UCLA Health study links long-term residential exposure to the pesticide chlorpyrifos with a more than 2.5-fold increase in Parkinson’s disease risk; animal experiments show chlorpyrifos damages dopamine neurons, triggers alpha-synuclein buildup, brain inflammation, and disrupts autophagy, the cellular protein-cleanup system, suggesting mechanisms and potential therapeutic targets and highlighting the importance of monitoring exposed individuals.
Engineers at the University of Edinburgh used engineered E. coli to break down PET plastic waste into L-DOPA, the main drug for Parkinson’s, creating a sustainable upcycling pathway from discarded bottles and signaling potential expansion to other products, with work now focusing on industrial scalability and environmental performance.